These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 18487510)

  • 1. BCR ligation induced by IgM stimulation results in gene expression and functional changes only in IgV H unmutated chronic lymphocytic leukemia (CLL) cells.
    Guarini A; Chiaretti S; Tavolaro S; Maggio R; Peragine N; Citarella F; Ricciardi MR; Santangelo S; Marinelli M; De Propris MS; Messina M; Mauro FR; Del Giudice I; Foà R
    Blood; 2008 Aug; 112(3):782-92. PubMed ID: 18487510
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential signaling via surface IgM is associated with VH gene mutational status and CD38 expression in chronic lymphocytic leukemia.
    Lanham S; Hamblin T; Oscier D; Ibbotson R; Stevenson F; Packham G
    Blood; 2003 Feb; 101(3):1087-93. PubMed ID: 12393552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained signaling through the B-cell receptor induces Mcl-1 and promotes survival of chronic lymphocytic leukemia B cells.
    Petlickovski A; Laurenti L; Li X; Marietti S; Chiusolo P; Sica S; Leone G; Efremov DG
    Blood; 2005 Jun; 105(12):4820-7. PubMed ID: 15728130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGHV unmutated CLL B cells are more prone to spontaneous apoptosis and subject to environmental prosurvival signals than mutated CLL B cells.
    Coscia M; Pantaleoni F; Riganti C; Vitale C; Rigoni M; Peola S; Castella B; Foglietta M; Griggio V; Drandi D; Ladetto M; Bosia A; Boccadoro M; Massaia M
    Leukemia; 2011 May; 25(5):828-37. PubMed ID: 21372840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stereotyped subset #1 chronic lymphocytic leukemia: a direct link between B-cell receptor structure, function, and patients' prognosis.
    Del Giudice I; Chiaretti S; Santangelo S; Tavolaro S; Peragine N; Marinelli M; Ilari C; Raponi S; Messina M; Nanni M; Mauro FR; Piciocchi A; Bontempi K; Rossi D; Gaidano G; Guarini A; Foà R
    Am J Hematol; 2014 Jan; 89(1):74-82. PubMed ID: 24030933
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of TOSO in CLL is triggered by B-cell receptor signaling and associated with progressive disease.
    Pallasch CP; Schulz A; Kutsch N; Schwamb J; Hagist S; Kashkar H; Ultsch A; Wickenhauser C; Hallek M; Wendtner CM
    Blood; 2008 Nov; 112(10):4213-9. PubMed ID: 18708628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinct gene expression patterns in chronic lymphocytic leukemia defined by usage of specific VH genes.
    Kienle D; Benner A; Kröber A; Winkler D; Mertens D; Bühler A; Seiler T; Jäger U; Lichter P; Döhner H; Stilgenbauer S
    Blood; 2006 Mar; 107(5):2090-3. PubMed ID: 16322480
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heightened BTK-dependent cell proliferation in unmutated chronic lymphocytic leukemia confers increased sensitivity to ibrutinib.
    Guo A; Lu P; Galanina N; Nabhan C; Smith SM; Coleman M; Wang YL
    Oncotarget; 2016 Jan; 7(4):4598-610. PubMed ID: 26717038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mimicking the tumour microenvironment of chronic lymphocytic leukaemia in vitro critically depends on the type of B-cell receptor stimulation.
    Rombout A; Lust S; Offner F; Naessens E; Verhasselt B; Philippé J
    Br J Cancer; 2016 Mar; 114(6):704-12. PubMed ID: 26924423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular and clinical features of chronic lymphocytic leukaemia with stereotyped B cell receptors: results from an Italian multicentre study.
    Bomben R; Dal Bo M; Capello D; Forconi F; Maffei R; Laurenti L; Rossi D; Del Principe MI; Zucchetto A; Bertoni F; Rossi FM; Bulian P; Cattarossi I; Ilariucci F; Sozzi E; Spina V; Zucca E; Degan M; Lauria F; Del Poeta G; Efremov DG; Marasca R; Gaidano G; Gattei V
    Br J Haematol; 2009 Feb; 144(4):492-506. PubMed ID: 19036101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural and functional features of the B-cell receptor in IgG-positive chronic lymphocytic leukemia.
    Potter KN; Mockridge CI; Neville L; Wheatley I; Schenk M; Orchard J; Duncombe AS; Packham G; Stevenson FK
    Clin Cancer Res; 2006 Mar; 12(6):1672-9. PubMed ID: 16551848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T-cell independent, B-cell receptor-mediated induction of telomerase activity differs among IGHV mutation-based subgroups of chronic lymphocytic leukemia patients.
    Damle RN; Temburni S; Banapour T; Paul S; Mongini PK; Allen SL; Kolitz JE; Rai KR; Chiorazzi N
    Blood; 2012 Sep; 120(12):2438-49. PubMed ID: 22875913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. IL-4 rescues surface IgM expression in chronic lymphocytic leukemia.
    Guo B; Zhang L; Chiorazzi N; Rothstein TL
    Blood; 2016 Jul; 128(4):553-62. PubMed ID: 27226435
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surface antigen expression and correlation with variable heavy-chain gene mutation status in chronic lymphocytic leukemia.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2003 Jan; 70(1):53-9. PubMed ID: 12631259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heterogeneous functional effects of concomitant B cell receptor and TLR stimulation in chronic lymphocytic leukemia with mutated versus unmutated Ig genes.
    Chatzouli M; Ntoufa S; Papakonstantinou N; Chartomatsidou E; Anagnostopoulos A; Kollia P; Ghia P; Muzio M; Stamatopoulos K; Belessi C
    J Immunol; 2014 May; 192(10):4518-24. PubMed ID: 24719462
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mitogen induced activation, proliferation and surface antigen expression patterns in unmutated and hypermutated chronic lymphocytic leukemia cells.
    Vilpo J; Tobin G; Hulkkonen J; Hurme M; Thunberg U; Sundström C; Vilpo L; Rosenquist R
    Eur J Haematol; 2005 Jul; 75(1):34-40. PubMed ID: 15946308
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ZAP-70 directly enhances IgM signaling in chronic lymphocytic leukemia.
    Chen L; Apgar J; Huynh L; Dicker F; Giago-McGahan T; Rassenti L; Weiss A; Kipps TJ
    Blood; 2005 Mar; 105(5):2036-41. PubMed ID: 15514014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.
    Dal Bo M; D'Agaro T; Gobessi S; Zucchetto A; Dereani S; Rossi D; Zaja F; Pozzato G; Di Raimondo F; Gaidano G; Laurenti L; Del Poeta G; Efremov DG; Gattei V; Bomben R
    Oncotarget; 2015 Aug; 6(22):19102-17. PubMed ID: 26036258
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CLL cells respond to B-Cell receptor stimulation with a microRNA/mRNA signature associated with MYC activation and cell cycle progression.
    Pede V; Rombout A; Vermeire J; Naessens E; Mestdagh P; Robberecht N; Vanderstraeten H; Van Roy N; Vandesompele J; Speleman F; Philippé J; Verhasselt B
    PLoS One; 2013; 8(4):e60275. PubMed ID: 23560086
    [TBL] [Abstract][Full Text] [Related]  

  • 20. ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia.
    Rassenti LZ; Huynh L; Toy TL; Chen L; Keating MJ; Gribben JG; Neuberg DS; Flinn IW; Rai KR; Byrd JC; Kay NE; Greaves A; Weiss A; Kipps TJ
    N Engl J Med; 2004 Aug; 351(9):893-901. PubMed ID: 15329427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.